Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-α production in murine macrophages

International Journal of Immunopharmacology

Volumn 21, Issue 7, 1999, Pages 435-443

  K , Rao Manjeet ^a   Ghosh, B ^a  

^a Ctr Biochem Technol Mall Rd D   (India)

Author keywords

Bacterial lipopolysaccharide (LPS); Nitric oxide (NO); Quercetin; Rhododendron cinnabarium; Tumor necrosis factor (TNF )

Indexed keywords

LIPOPOLYSACCHARIDE; NITRIC OXIDE; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PLANT; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; FEMALE; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NITRIC OXIDE; QUERCETIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344327080     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00024-7     Document Type: Article

References (22)

1. Casale T.B., Costa J.J., Galli S.J. TNF-α is important in human lung allergic reactions. Am J Respi Cell Mol Biol. 25:1996;35-44.
2. Kindler V., Sappino P.A., Grau E.G., Piguet F.P., Vassali P. The inducing role of tumor necrosis factor in the development of bacterial granulomas during BCG infections. Cell. 56:1989;731-740.
3. Lehmann V., Freudenberg M.A., Galnos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine treated mice. J Exp Med. 165:1987;657-663.
4. Cohen S.P., Nakhastri H., Dennis J., Caragine T., Bianchi M., Cerami A., Tracey K.J. CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc Natl Acad Sci, USA. 93:1996;3967-3971.
5. Schow R.S., Joly A. ALLN inhibits LPS induced NF-κB activation and prevents TNF-α and IL-6 synthesis in vivo. Cellular Immunol. 175:1997;199-202.
6. Haas M., Page S., Page M., Neumann F.J., Marx N., Adam M., Ziegler-Heitbrock H.W., Neumeier D., Brand K. Effect of proteasome inhibitors on monocytic kappa-alpha and -beta depletion, NF-kappaB activation, and cytokine production. J Leukoc Biol. 63:1998;395-404.
7. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
8. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem. 269:1994;4705-4708.
9. Chen C.K., Asciak C.R. Vasorelaxing activity of reserveratol and quercetin in isolated rat aorta. Gen Pharmacol. 27:1996;363-366.
10. Chiesi M., Schwaller R. Inhibition of constitutive endothelial NO synthase activity by tannin and quercetin. Biochem Pharmacol. 49:1995;495-501.
11. Tamura M. Effects of Flavanoid compounds on the activity of NAPDH diapharose prepared from mouse brain. Jpn J Pharmacol. 65:1994;371-373.
12. Kawada N., Seki S., Inoue M., Kuroki T. Effect of antioxidants, reserveratol, quercetin and N-acetyl cystene on the function of cultured rat hepatic stellate cells and kuffer cells. Hepatology. 27:1998;1265-1274.
13. Svensson U., Holst E., Sundler R. Cyclosporin sensitive expression of cytokine mRNA in mouse macrophages responding to bacteria. Mol Immunol. 32:1995;157-165.
14. Kasai K., Hattori Y., Nakanishi N., Manaka K., Banba N., Motohashi S., Shimoda S. Regulation of inducible nitric oxide synthase production by cytokines in human thyrocytes in culture. Endocrinology. 136:1995;4261-4270.
15. Csch K., Beutler B. Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein. J Biol Chem. 264:1989;16,256-16,260.
16. Mizatovic T., Veronique K., Daniel C., Patric D., Georges H. IL4 and IL-13 inhibit TNF-a mRNA translation activation in LPS induced mouse macrophages. J Biol Chem. 272:1997;14,394-14,398.
17. Liew F.Y. Regulation of lymphocyte function by nitric oxide. Curr Opi In Immunol. 7:1995;396-399.
18. Feshel K., Kroneke K.D., Meyer K.L., Huber H., Walu V., Kolb-Bachofen V. Nitric oxide induces apoptosis in mouse thymocytes. J Immunol. 155:1995;2858-2865.
19. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S., Keefer L.K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1991;1001-1003.
20. Eigler A., Sinha B., Hartman G., Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunology Today. 18:1997;487-492.
21. Shakhov A.N., Collart M.A., Vassali P., Nedospasov S.A., Jongeneel C.V. κB-type enhancers are involved in lipopolysaccharide mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J Exp Med. 171:1990;35-47.
22. Hu Z.L., Qian D.H. Effects of protein kinase C activator and inhibitor on release of tumor necrosis factor from mouse peritoneal macrophages. Chung Kuo Yao Li Hsueh Pao. 14:1993;183-186.